Canada: POC (point-of-care) devices for OAT (oral anticoagulation therapy) improve health, can reduce costs and need investment
This article was originally published in Clinica
Executive Summary
Canada has found that portable point-of-care (POC) devices to monitor long-term oral anticoagulation therapy (OAT) "compare with standard laboratory testing in clinical and cost effectiveness", but additional resources are required. This is the conclusion of a report published this month by the Canadian Agency for Drugs and Technologies in Health (CADTH).